Literature DB >> 22918473

Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation.

J Pan1, N J S Fauzee, Y-l Wang, Y-T Sheng, Y Tang, J-Q Wang, W-q Wu, J-x Yan, J Xu.   

Abstract

Our aim was to investigate the influence of silencing poly-(ADP-ribose)glycohydrolase (PARG) in human colon carcinoma LoVo cells on the ability of human umbilical vein endothelial cell (HUVEC) migration, proliferation and its possible mechanisms. PARG mRNA expression was detected by reverse transcriptase (RT) and real-time-PCR. PARG, poly-(ADP-ribose)polymerase (PARP), p38, p-p38, extracellular signal-regulated kinase (ERK), p-ERK, nuclear factor (NF)-κB, phosphorylated IκBα (p-IκBα), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), intercellular cell adhesion molecule (ICAM)-1 and matrix metalloproteinases (MMP)-9 expressions were detected by western blot. The influence of PARG-short hairpin (sh)RNA on the ability of HUVEC migration and proliferation were observed by transwell migration and Counting Kit-8 (CCK-8) assay. Both RT-PCR and western blot results showed that the expression of PARG in PARG-shRNA cells was decreased and expressions of PARP, p38, p-p38, ERK, p-ERK, NF-κB, p-IκBα, VEGF, b-FGF, ICAM-1 and MMP-9 in those cells were lower than that in the untransfected and control-shRNA groups (P<0.05). Migration assay showed that migratory inhibition rate for HUVEC was decreased (55.23%) in cocultured PARG-shRNA cells; moreover, CCK-8 assay showed that the proliferation of HUVECs cultured with the supernatant of PARG-shRNA cells was also comparatively lower. Hence, concluding that PARG silencing could inhibit the ability of HUVEC migration and proliferation by downregulating the activity of NF-κB in LoVo cells that in turn decreases angiogenic factors such as VEGF, b-FGF, ICAM-1, MMP-9, as well as phosphorylation of p38 and ERK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918473     DOI: 10.1038/cgt.2012.48

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  6 in total

1.  MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.

Authors:  Xu Qian; Jing Yu; Yu Yin; Jun He; Lin Wang; Qi Li; Lou-Qian Zhang; Chong-Yong Li; Zhu-Mei Shi; Qing Xu; Wei Li; Li-Hui Lai; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Cell Cycle       Date:  2013-04-08       Impact factor: 4.534

2.  Is there an epigenetic component underlying the resistance of triple-negative breast cancers to parp inhibitors?

Authors:  Amanda Lovato; Lawrence Panasci; Michael Witcher
Journal:  Front Pharmacol       Date:  2012-12-27       Impact factor: 5.810

3.  Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.

Authors:  Lianne E Rotin; Marcela Gronda; Neil MacLean; Rose Hurren; XiaoMing Wang; Feng-Hsu Lin; Jeff Wrana; Alessandro Datti; Dwayne L Barber; Mark D Minden; Malik Slassi; Aaron D Schimmer
Journal:  Oncotarget       Date:  2016-01-19

4.  Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations.

Authors:  Yimeng Zhou; Ning Li; Zhixia Qiu; Xiaoyu Lu; Min Fang; Xijing Chen; Lili Ren; Guangji Wang; Pingkai Ouyang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  The Sound of Silence: RNAi in Poly (ADP-Ribose) Research.

Authors:  Christian Blenn; Philippe Wyrsch; Felix R Althaus
Journal:  Genes (Basel)       Date:  2012-12-06       Impact factor: 4.096

6.  Proximal ADP-ribose Hydrolysis in Trypanosomatids is Catalyzed by a Macrodomain.

Authors:  Teemu Haikarainen; Lari Lehtiö
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.